| | | 65727 | | 25.11.2016 | | Acino Pharma AG | | | | | | | 24.11.2021 | | | | | | | | | | 01.01.30. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Epethinan 5 mg/2.5 mg | Retardtabletten | Retard-Tabletten (Oxycodon-Hydrochlorid 5 mg, Naloxon Hydrochlorid Anhydrid 2.5 mg) | N02AA55 | PI | | 02 | Epethinan 10 mg/5 mg | Retardtabletten | Retard-Tabletten (Oxycodon-Hydrochlorid 10 mg, Naloxon Hydrochlorid Anhydrid 5 mg) | N02AA55 | PI | | 03 | Epethinan 20 mg/10 mg | Retardtabletten | Retard-Tabletten (Oxycodon-Hydrochlorid 20 mg, Naloxon Hydrochlorid Anhydrid 10 mg) | N02AA55 | PI | | 04 | Epethinan 40 mg/20 mg | Retardtabletten | Retard-Tabletten (Oxycodon-Hydrochlorid 40 mg, Naloxon Hydrochlorid Anhydrid 20 mg) | N02AA55 | PI |
|
|
